We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Snibe Co.,Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe) is a global leader in the IVD field, with 30 years o... read more Featured Products: More products

Download Mobile App





SNIBE Showcases Total Lab Automation and Diagnostic Platforms at ADLM 2026

By LabMedica International staff writers
Posted on 30 Jul 2026

SNIBE is presenting its latest in vitro diagnostic and laboratory automation solutions at ADLM 2026 in Anaheim, California, where attendees can visit the company at Booth 3814. More...

The exhibit highlights SNIBE’s focus on integrated diagnostic workflows spanning immunoassay, clinical chemistry, automation, and broader laboratory testing needs.

A central focus of the exhibit is SATLARS mini-T8, the newest member of SNIBE’s Total Laboratory Automation Solutions. Designed for laboratories with limited space, the system integrates pre-analytical and post-analytical sample handling within a compact 2.2 m² footprint. It automates the sample handling and analysis process from loading to storage, while supporting rapid turnaround through compatibility with SNIBE’s high-throughput analyzers.

SNIBE is also showcasing its integrated and high-throughput testing systems, including the Biolumi CX Solution-X10+C10, which combines the MAGLUMI X10 immunoassay analyzer with the Biossays C10 biochemistry analyzer. The system enables immunoassay, biochemical, and ISE testing from one sample loading process, reducing sample transfer steps and helping laboratories improve testing efficiency.

The company’s MAGLUMI X8 chemiluminescence immunoassay system is designed for medium- to large-volume laboratories, offering up to 600 tests per hour in a single module and up to 2,400 tests per hour when four modules are combined. SNIBE’s Biossays C10 biochemistry analyzer further supports high-throughput workflows, with up to 2,000 biochemistry tests per hour, 1,000 ISE tests per hour, whole-blood HbA1c testing, and connectivity with laboratory automation systems.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.